161 related articles for article (PubMed ID: 32151128)
1. Serum Galectin-3 Levels in Children with Attention-Deficit/Hyperactivity Disorder.
Isık Ü; Kılıç F; Demirdas A; Aktepe E; Aydogan Avsar P
Psychiatry Investig; 2020 Mar; 17(3):256-261. PubMed ID: 32151128
[TBL] [Abstract][Full Text] [Related]
2. Serum zonulin and claudin-5 levels in children with attention-deficit/hyperactivity disorder.
Aydoğan Avşar P; Işık Ü; Aktepe E; Kılıç F; Doğuç DK; Büyükbayram Hİ
Int J Psychiatry Clin Pract; 2021 Mar; 25(1):49-55. PubMed ID: 32757874
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of cortisol, dehydroepiandrosterone, and oxytocin in children with attention-deficit/hyperactivity disorder combined presentation with and without comorbid conduct disorder.
Işık Ü; Bilgiç A; Toker A; Kılınç I
Psychiatry Res; 2018 Mar; 261():212-219. PubMed ID: 29324397
[TBL] [Abstract][Full Text] [Related]
4. Serum brain-derived neurotrophic factor, glial-derived neurotrophic factor, nerve growth factor, and neurotrophin-3 levels in children with attention-deficit/hyperactivity disorder.
Bilgiç A; Toker A; Işık Ü; Kılınç İ
Eur Child Adolesc Psychiatry; 2017 Mar; 26(3):355-363. PubMed ID: 27561780
[TBL] [Abstract][Full Text] [Related]
5. Galectin-3 levels in school aged children with autism spectrum disorder.
Artık A; Kocaman O; Kara H; Tuncer SÇ
Int J Dev Disabil; 2023; 69(5):757-761. PubMed ID: 37547549
[No Abstract] [Full Text] [Related]
6. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
Klassen AF; Miller A; Fine S
Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
[TBL] [Abstract][Full Text] [Related]
7. Elevated Serum Galectin-1 and Galectin-3 Levels in Children With Specific Learning Disorder: A Case Control Study.
Tanır Y; Gülle ZN; Uncu GS; Baki AM; Vural P; Soylu N; Örengül AC
Psychiatry Investig; 2023 Jul; 20(7):609-615. PubMed ID: 37409365
[TBL] [Abstract][Full Text] [Related]
8. Emotional lability in children and adolescents with attention deficit/hyperactivity disorder (ADHD): clinical correlates and familial prevalence.
Sobanski E; Banaschewski T; Asherson P; Buitelaar J; Chen W; Franke B; Holtmann M; Krumm B; Sergeant J; Sonuga-Barke E; Stringaris A; Taylor E; Anney R; Ebstein RP; Gill M; Miranda A; Mulas F; Oades RD; Roeyers H; Rothenberger A; Steinhausen HC; Faraone SV
J Child Psychol Psychiatry; 2010 Aug; 51(8):915-23. PubMed ID: 20132417
[TBL] [Abstract][Full Text] [Related]
9. Low serum allopregnanolone levels in children with attention deficit hyperactivity disorder.
Şahin İ; Say GN; Avcı B; Kesim N
Psychoneuroendocrinology; 2022 Dec; 146():105923. PubMed ID: 36152454
[TBL] [Abstract][Full Text] [Related]
10. Serum Tumor Necrosis Factor-Like Weak Inducer of Apoptosis (TWEAK) Levels Are Decreased in Children with Attention-Deficit/Hyperactivity Disorder.
Işık Ü; Kılıç F; Demirdaş A; Aktepe E; Aydoğan Avşar P
Psychiatr Danub; 2022; 34(1):51-56. PubMed ID: 35467610
[TBL] [Abstract][Full Text] [Related]
11. High pretreatment cognitive impulsivity predicts response of oppositional symptoms to methylphenidate in patients with attention-deficit hyperactivity disorder/oppositional defiant disorder.
Golubchik P; Shalev L; Tsamir D; Manor I; Weizman A
Int Clin Psychopharmacol; 2019 May; 34(3):138-142. PubMed ID: 30640748
[TBL] [Abstract][Full Text] [Related]
12. Patterns of comorbidity associated with subtypes of attention-deficit/hyperactivity disorder among 6- to 12-year-old children.
Eiraldi RB; Power TJ; Nezu CM
J Am Acad Child Adolesc Psychiatry; 1997 Apr; 36(4):503-14. PubMed ID: 9100425
[TBL] [Abstract][Full Text] [Related]
13. Neurocognitive function in attention-deficit-hyperactivity disorder with and without comorbid disruptive behaviour disorders.
Barnett R; Maruff P; Vance A
Aust N Z J Psychiatry; 2009 Aug; 43(8):722-30. PubMed ID: 19629793
[TBL] [Abstract][Full Text] [Related]
14. Attention-deficit-hyperactivity disorder with and without oppositional defiant disorder in 3- to 7-year-old children.
Kadesjö C; Hägglöf B; Kadesjö B; Gillberg C
Dev Med Child Neurol; 2003 Oct; 45(10):693-9. PubMed ID: 14515941
[TBL] [Abstract][Full Text] [Related]
15. Conduct behaviors and oppositional defiant behaviors in children and adolescents with ADHD.
Ghanizadeh A
Postgrad Med; 2015 Apr; 127(3):289-94. PubMed ID: 25676142
[TBL] [Abstract][Full Text] [Related]
16. [Family functioning and psychosocial characteristics in children with attention deficit hyperactivity disorder with comorbid oppositional defiant disorder or conduct disorder].
Kiliç BG; Sener S
Turk Psikiyatri Derg; 2005; 16(1):21-8. PubMed ID: 15793695
[TBL] [Abstract][Full Text] [Related]
17. Parent SNAP-IV rating of attention-deficit/hyperactivity disorder: accuracy in a clinical sample of ADHD, validity, and reliability in a Brazilian sample.
Costa DS; de Paula JJ; Malloy-Diniz LF; Romano-Silva MA; Miranda DM
J Pediatr (Rio J); 2019; 95(6):736-743. PubMed ID: 30236592
[TBL] [Abstract][Full Text] [Related]
18. Empathy and Facial Expression Recognition in Children With and Without Attention-Deficit/Hyperactivity Disorder: Effects of Stimulant Medication on Empathic Skills in Children with Attention-Deficit/Hyperactivity Disorder.
Gumustas F; Yilmaz I; Yulaf Y; Gokce S; Sabuncuoglu O
J Child Adolesc Psychopharmacol; 2017 Jun; 27(5):433-439. PubMed ID: 28332851
[TBL] [Abstract][Full Text] [Related]
19. Implementing the American Academy of Pediatrics attention-deficit/hyperactivity disorder diagnostic guidelines in primary care settings.
Leslie LK; Weckerly J; Plemmons D; Landsverk J; Eastman S
Pediatrics; 2004 Jul; 114(1):129-40. PubMed ID: 15231919
[TBL] [Abstract][Full Text] [Related]
20. [Comorbidities and functional impairments in children with attention deficit hyperactivity disorder].
Xiao ZH; Wang QH; Luo TT; Zhong L
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Sep; 15(9):728-32. PubMed ID: 24034913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
